Глава 7. Атопический дерматит

Larralde M. Langerhans cell histiocytosis in children under one year // Arch. Argent. Pediatr. 2008. Vol. 106. N. 3. P. 269–272.

Leung M.B.D. Atopic dermatitis: a disease of altered skin barrier and immune dysregulation // Imunnol. Rev. 2011. Vol. 242. N. 1. P. 233–246.

Levin J., Friedlander S.F., Del Rosso J.Q. Atopic dermatitis and the stratum corneum — part 1: the role of filaggrin in the stratum corneum barrier and atopic skin // J. Clin. Aesthet. Dermatol. 2013. Vol. 6. N. 10. P. 16–22.

Levin J., Friedlander S.F., Del Rosso J.Q. Atopic dermatitis and the stratum corneum — part 2: other structural and functional characteristics of the stratum corneum barrier in atopic skin // J. Clin. Aesthet. Dermatol. 2013. Vol. 6. N. 11. P. 49–54.

Lyons J.J., Milner J.D., Stone K.D. Atopic dermatitis in children: clinical features, pathophysiology, and treatment // Immunol. Allergy Clin. North Am. 2015. Vol. 35. N 1. P. 161–183.

McGrath J.A. Filaggrin and skin barrier defects // Australas. J. Dermatol. 2008. Vol. 49. P. 67–74.

Minkov M. Multisystem Langerhans cell histiocytosis in children // Paediatr. Drugs. 2011. Vol. 13. N. 2. P. 75–86.

Mohan G.C., Lio P.A. Comparison of dermatology and allergy guidelines for atopic dermatitis management // JAMA Dermatol. 2015. Vol. 151. P. 1009–1013.

Mori T., Ishida K., Mukumoto S. et al. Comparison of skin barrier function and sensory nerve electric current perception threshold between IgE-high extrinsic and IgE-normal intrinsic types of atopic dermatitis // Br. J. Dermatol. 2010. Vol. 162. N. 1. P. 83–90.

Morizane S., Yamasaki K., Kajita A. et al. TH2 cytokines increase kallikrein 7 expression and function in patients with atopic dermatitis // J. Allergy Clin. Immunol. 2012. Vol. 130. N. 1. P. 259–261.

Nidner R. Therapy with systemic glucocorticoids // Hautartzt. 2001. Vol. 52. P. 1062–1071.

Novak N., Simon D. Atopic dermatitis — from new pathophysiologic insights to individualized therapy // Allergy. 2011. Vol. 66. P. 830–839.

Nowicka D., Grywalska E. The role of immune defects and colonization of Staphylococcus aureus in the pathogenesis of atopic dermatitis // Anal. Cell. Pathol. (Amst.). 2018. Vol. 2018. Article ID 1956403.

Oji V., Eckl K.M., Aufenvenne K. et al. Loss of corneodesmosin leads to severe skin barrier defect, pruritus, and atopy: unraveling the peeling skin disease // Am. J. Hum. Genet. 2010. Vol. 87. N. 2. P. 274–281.

Otsuka A., Nomura T., Rerknimitr P. et al. The interplay between genetic and environmental factors in the pathogenesis of atopic dermatitis // Immunol. Rev. 2017. Vol. 278. N. 1. P. 246–262.

Paller A.S., Siegfried E.C., Thaçi D. et al. Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: a randomized, double-blinded, placebo-controlled phase 3 trial // J. Am. Acad. Dermatol. 2020. Vol. 83. N. 5. P. 1282–1293.

Paller A.S., Tom W.L., Lebwohl M.G. et al. Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults // J. Am. Acad. Dermatol. 2016. Vol. 75. N. 3. P. 494–503.

Parker J.J., Sugarman J.L., Silverberg N.B. et al. Psoriasiform dermatitis during dupilumab treatment for moderate-to-severe atopic dermatitis in children // Pediatr. Dermatol. 2021. Vol. 38. P. 1500–1505. DOI: https://doi.org/10.1111/pde.14820.

Peng W., Novak N. Pathogenesis of atopic dermatitis // Clin. Exp. Allergy. 2015. Vol. 45. N. 3. P. 566–574.

Puar N., Chovatiya R., Paller A.S. New treatments in atopic dermatitis // Ann. Allergy Asthma Immunol. 2021. Vol. 126. N 1. P. 21–31.

Rerknimitr P., Otsuka A., Nakashima C., Kabashima K. The etiopathogenesis of atopic dermatitis: barrier disruption, immunological derangement, and pruritus // Inflamm. Regen. 2017. Vol. 37. N. 1. P. 14.

Ring J., Alomar A., Bieber T. et al. Guidelines for treatment of atopic eczema (atopic dermatitis) part I // J. Eur. Acad. Dermatol. Venereol. 2012. Vol. 26. N. 8. P. 1045–1060.

Ring J., Alomar A., Bieber T. et al. Guidelines for treatment of atopic eczema (atopic dermatitis) part II // J. Eur. Acad. Dermatol. Venereol. 2012. Vol. 26. N. 9. P. 1176–1193.

Samuelov L., Sarig O., Harmon R.M. et al. Desmoglein 1 deficiency results in severe dermatitis, multiple allergies and metabolic wasting // Nat. Genet. 2013. Vol. 45. N. 10. P. 1244–1248.

Scharschmidt T.C., Man M.-Q., Hatano Y. et al. Filaggrin deficiency confers a paracellular barrier abnormality that reduces inflammatory thresholds to irritants and haptens // J. Allergy Clin. Immunol. 2009. Vol. 124. N. 3. P. 496–506.

Scheerer C., Eyerich K. Pathogenese des atopischen Ekzems // Hautarzt. 2018. Vol. 69. N. 3. P. 191–196.

Seegraber M., Srour J., Walter A. et al. Dupilumab for treatment of atopic dermatitis // Expert Rev. Clin. Pharmacol. 2018. Vol. 11. N. 5. P. 467–474.

Shmidt E., Levitt J. Dermatologic infestations // Int. J. Dermatol. 2012. Vol. 51. N. 2. P. 131–141.

Sidbury R., Davis D.M., Cohen D.E. et al. Guidelines of care for the management of atopic dermatitis, section 3: Management and treatment with phototherapy and systemic agents // J. Am. Acad. Dermatol. 2014. Vol. 71. N. 2. P. 327–349.

Sidbury R., Tom W.L., Bergman J.N. et al. Guidelines of care for the management of atopic dermatitis, section 4: Prevention of disease flares and use of adjunctive therapies and approaches // J. Am. Acad. Dermatol. 2014. Vol. 71. N. 6. P. 1218–1233.

Smith F.J.D., Irvine A.D., Terron-Kwiatkowski A. et al. Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris // Nat. Genet. 2006. Vol. 38. N. 3. P. 337–342.

Suarez-Farinas M., Dhingra N., Gittler J. et al. Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis // J. Allergy Clin. Immunol. 2013. Vol. 132. N. 2. P. 361–370.

Tavil B., Erdem A.Y., Azik F. et al. Successful allogeneic hemopoietic stem cell transplantation in a case of Wiskott-Aldrich syndrome and non-Hodgkin lymphoma // Pediatr. Transplant. 2013. Vol. 17. N. 6. P. E146–E148.

Thyssen J.P., Godoy-Gijon E., Elias P.M. Ichthyosis vulgaris: the filaggrin mutation disease // Br. J. Dermatol. 2013. Vol. 168. P. 1155–1166.

Tokura Y. Extrinsic and intrinsic types of atopic dermatitis // J. Dermatol. Sci. 2010. Vol. 58. N. 1. P. 1–7.

Tom W.L., Eichenfield L.F. Eczematous disorders // Neonatal and Infant Dermatology / Eds L.F. Eichenfield, I.J. Frieden, E.F. Mathes, A.L. Zaenglein. 3rd ed. Elsevier, 2015. P. 216–232.

Vasilopoulos Y., Sharaf N., di Giovine F. et al. The 3′-UTR AACCins5874 in the stratum corneum chymotryptic enzyme gene (SCCE/KLK7), associated with atopic dermatitis; causes an increased mRNA expression without altering its stability // J. Dermatol. Sci. 2011. Vol. 61. N. 2. P. 131–133.

Weidinger S., Beck L.A., Bieber T. et al. Atopic dermatitis // Nat. Rev. Dis. Prim. 2018. Vol. 4. P. 1.

Weidinger S., O’Sullivan M., Illig T. et al. Filaggrin mutations, atopic eczema, hay fever, and asthma in children // J. Allergy Clin. Immunol. 2008. Vol. 121. N. 5. P. 1203–1209.

Wollenberg A., Barbarot S., Bieber T. et al. Consensus-based European Guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I // J. Eur. Acad. Dermatol. Venereol. 2018. Vol. 32. N. 5. P. 657–682.

Wollenberg A., Barbarot S., Bieber T. et al. Consensus-based European Guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II // J. Eur. Acad. Dermatol. Venereol. 2018. Vol. 32. N. 6. P. 850–878.

Yang G., Seok J.K., Kang H.C. et al. Skin barrier abnormalities and immune dysfunction in atopic dermatitis // Int. J. Mol. Sci. 2020. Vol. 21. N. 8. P. 2867.

Zhang L.Y., Tian W., Shu L. et al. Clinical features, STAT3 gene mutations and Th17 cell analysis in nine children with hyper-IgE syndrome in Mainland China // Scand. J. Immunol. 2013. Vol. 78. N. 3. P. 258–265.

Zhao L.P., Di Z., Zhang L. et al. Association of SPINK5 gene polymorphisms with atopic dermatitis in Northeast China // J. Eur. Acad. Dermatol. Venereol. 2012. Vol. 26. N. 5. P. 572–577.